SCHEMBL18907273

SCHEMBL18907273

c1ccc(-c2nc3cc4ccccc4cc3c3c2cc(-c2c4ccccc4c(-c4cc5ccccc5c5c4oc4cc6ccccc6cc45)c4ccccc24)c2ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.38
ESR2 Q92731 6/20 0.38
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALOX5 P09917 1/20 0.32
ADORA2A P29274 1/20 0.32
NUDT1 P36639 1/20 0.32
CYP1A2 P05177 2/20 0.31
TP53 P04637 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
CSF1R P07333 1/20 0.30
PDGFRB P09619 1/20 0.30
MAPT P10636 1/20 0.30
KIT P10721 1/20 0.30
FLT3 P36888 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17589566 0.95 ESR1 (0.36) ESR1ESR2KDM4ELMNAALOX5
SCHEMBL18907189 0.92 ESR1 (0.37) ESR1ESR2KDM4ELMNASMN1; SMN2
SCHEMBL17589568 0.88 GPR84 (0.35) ESR1ESR2GPR84CYP1A1
SCHEMBL17589498 0.87 ESR1 (0.35) ESR1ESR2KDM4ELMNASMN1; SMN2
SCHEMBL18907256 0.87 CYP1A1 (0.33) KDM4EALOX5CYP1A2TP53CYP2C19
SCHEMBL17589565 0.86 CYP11B1 (0.40) KDM4ECYP1A2HSD17B10MEN1KMT2A
SCHEMBL18907405 0.85 SOS1 (0.34) ESR1ESR2KDM4ECYP1A2MEN1
SCHEMBL17589527 0.85 MEN1 (0.35) ESR1ESR2KDM4EADORA2ANUDT1
SCHEMBL17589549 0.83 MEN1 (0.40) ESR1ESR2KDM4EALOX5ADORA2A
SCHEMBL18907282 0.83 KDM4E (0.34) ESR1ESR2KDM4ELMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 ESR1 114/4885ESR2 456/4885KDM4E 2914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.